Brent Sabatini's most recent trade in Vir Biotechnology Inc was a trade of 40,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | Brent Sabatini | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Brent Sabatini | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 20,000 | 48,189 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Brent Sabatini | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.45 per share. | 22 Feb 2025 | 1,562 | 46,627 (0%) | 0% | 9.5 | 14,766 | Common Stock |
| Vir Biotechnology Inc | Brent Sabatini | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 9.15 per share. | 13 Feb 2025 | 1,562 | 28,189 (0%) | 0% | 9.1 | 14,291 | Common Stock |